BACKGROUND: Recent studies of children and adolescents who were exposed to radioactive iodine-131 (I-131) after the 1986 Chernobyl nuclear accident in Ukraine exhibited a significant dose-related increase in the risk of thyroid cancer, but the association of radiation doses with tumor histologic and morphologic features is not clear. METHODS: A cohort of 11,664 individuals in Belarus who were aged ≤18 years at the time of the accident underwent 3 cycles of thyroid screening during 1997 to 2008. I-131 thyroid doses were estimated from individual thyroid activity measurements taken within 2 months after the accident and from dosimetric questionnaire data. Demographic, clinical, and tumor pathologic characteristics of the patients with thyroid cancer were analyzed using 1-way analysis of variance, chi-square tests or Fisher exact tests, and logistic regression. RESULTS: In total, 158 thyroid cancers were identified as a result of screening. The majority of patients had T1a and T1b tumors (93.7%), with many positive regional lymph nodes (N1; 60.6%) but few distant metastases (M1; <1%). Higher I-131 doses were associated with higher frequency of solid and diffuse sclerosing variants of thyroid cancer (P < .01) and histologic features of cancer aggressiveness, such as lymphatic vessel invasion, intrathyroidal infiltration, and multifocality (all P < .03). Latency was not correlated with radiation dose. Fifty-two patients with self-reported thyroid cancers which were diagnosed before 1997 were younger at the time of the accident and had a higher percentage of solid variant cancers compared with patients who had screening-detected thyroid cancers (all P < .0001). CONCLUSIONS: I-131 thyroid radiation doses were associated with a significantly greater frequency of solid and diffuse sclerosing variants of thyroid cancer and various features of tumor aggressiveness.
BACKGROUND: Recent studies of children and adolescents who were exposed to radioactive iodine-131 (I-131) after the 1986 Chernobyl nuclear accident in Ukraine exhibited a significant dose-related increase in the risk of thyroid cancer, but the association of radiation doses with tumor histologic and morphologic features is not clear. METHODS: A cohort of 11,664 individuals in Belarus who were aged ≤18 years at the time of the accident underwent 3 cycles of thyroid screening during 1997 to 2008. I-131 thyroid doses were estimated from individual thyroid activity measurements taken within 2 months after the accident and from dosimetric questionnaire data. Demographic, clinical, and tumor pathologic characteristics of the patients with thyroid cancer were analyzed using 1-way analysis of variance, chi-square tests or Fisher exact tests, and logistic regression. RESULTS: In total, 158 thyroid cancers were identified as a result of screening. The majority of patients had T1a and T1b tumors (93.7%), with many positive regional lymph nodes (N1; 60.6%) but few distant metastases (M1; <1%). Higher I-131 doses were associated with higher frequency of solid and diffuse sclerosing variants of thyroid cancer (P < .01) and histologic features of cancer aggressiveness, such as lymphatic vessel invasion, intrathyroidal infiltration, and multifocality (all P < .03). Latency was not correlated with radiation dose. Fifty-two patients with self-reported thyroid cancers which were diagnosed before 1997 were younger at the time of the accident and had a higher percentage of solid variant cancers compared with patients who had screening-detected thyroid cancers (all P < .0001). CONCLUSIONS:I-131 thyroid radiation doses were associated with a significantly greater frequency of solid and diffuse sclerosing variants of thyroid cancer and various features of tumor aggressiveness.
Authors: L E Holm; K E Wiklund; G E Lundell; N A Bergman; G Bjelkengren; U B Ericsson; E S Cederquist; M E Lidberg; R S Lindberg; H V Wicklund Journal: J Natl Cancer Inst Date: 1989-02-15 Impact factor: 13.506
Authors: E Ron; J H Lubin; R E Shore; K Mabuchi; B Modan; L M Pottern; A B Schneider; M A Tucker; J D Boice Journal: Radiat Res Date: 1995-03 Impact factor: 2.841
Authors: L E Holm; P Hall; K Wiklund; G Lundell; G Berg; G Bjelkengren; E Cederquist; U B Ericsson; A Hallquist; L G Larsson Journal: J Natl Cancer Inst Date: 1991-08-07 Impact factor: 13.506
Authors: Valentin A Stezhko; Elena E Buglova; Larissa I Danilova; Valentina M Drozd; Nikolaj A Krysenko; Nadia R Lesnikova; Victor F Minenko; Vladislav A Ostapenko; Sergey V Petrenko; Olga N Polyanskaya; Valery A Rzheutski; Mykola D Tronko; Olga O Bobylyova; Tetyana I Bogdanova; Ovsiy V Ephstein; Iryna A Kairo; Olexander V Kostin; Ilya A Likhtarev; Valentin V Markov; Valery A Oliynik; Viktor M Shpak; Valeriy P Tereshchenko; Galina A Zamotayeva; Gilbert W Beebe; Andre C Bouville; Aaron B Brill; John D Burch; Daniel J Fink; Ellen Greenebaum; Geoffrey R Howe; Nickolas K Luckyanov; Ihor J Masnyk; Robert J McConnell; Jacob Robbins; Terry L Thomas; Paul G Voillequé; Lydia B Zablotska Journal: Radiat Res Date: 2004-04 Impact factor: 2.841
Authors: E D Williams; A Abrosimov; T Bogdanova; E P Demidchik; M Ito; V LiVolsi; E Lushnikov; J Rosai; Yu Sidorov; M D Tronko; A F Tsyb; S L Vowler; G A Thomas Journal: Br J Cancer Date: 2004-06-01 Impact factor: 7.640
Authors: Michael G White; Nicole A Cipriani; Layth Abdulrasool; Sharone Kaplan; Briseis Aschebrook-Kilfoy; Peter Angelos; Edwin L Kaplan; Raymon H Grogan; Kenan Onel Journal: Thyroid Date: 2016-08 Impact factor: 6.568
Authors: Tetiana I Bogdanova; Vladimir A Saenko; Alina V Brenner; Liudmyla Yu Zurnadzhy; Tatiana I Rogounovitch; Ilya A Likhtarov; Sergii V Masiuk; Leonila M Kovgan; Victor M Shpak; Geraldine A Thomas; Stephen J Chanock; Kiyohiko Mabuchi; Mykola D Tronko; Shunichi Yamashita Journal: Thyroid Date: 2018-07 Impact factor: 6.568
Authors: Lydia B Zablotska; Eldar A Nadyrov; Olga N Polyanskaya; Robert J McConnell; Patrick O'Kane; Jay Lubin; Maureen Hatch; Mark P Little; Alina V Brenner; Ilya V Veyalkin; Vasilina V Yauseyenka; Andre Bouville; Vladimir V Drozdovitch; Viktor F Minenko; Yuri E Demidchik; Kiyohiko Mabuchi; Alexander V Rozhko Journal: Am J Epidemiol Date: 2015-10-05 Impact factor: 4.897